From Medscape Special Reports

Special Report: Rethinking Uterine Morcellation

April 26, 2014


FDA Warns Against Morcellation in Hysterectomy, Myomectomy
The FDA is discouraging the use of laparoscopic power morcellators because of the risk of spreading cancerous tissue, which could significantly worsen the patient's likelihood of long-term survival.

The Morcellation Controversy: A Timeline
Read a summary of major events leading up to the FDA warning against morcellation in hysterectomy and myomectomy.

Hysteroscopic Morcellation Better for Endometrial Polyp Removal
Office-based hysteroscopic morcellation may be quicker, more effective, and less painful than electrosurgical resection for endometrial polyp removal.


Is There a Future for Morcellation in Gynecologic Surgery?
AAGL Board Member Jubilee Brown, MD, reacts to the recent FDA statement that power morcellation shouldn't be used for hysterectomy or myomectomy in most women with uterine fibroids.

Is It Time to Revisit Uterine Morcellation?
Dr. Andrew Kaunitz explains why current controversy surrounding the use of electric morcellation for minimally invasive hysterectomy is focusing more attention on tissue extraction alternatives.

Editor's Note

The FDA says power morcellators should no longer be used for hysterectomy or myomectomy in most women with uterine fibroids. Here’s everything you need to know about the controversy leading up to this announcement and how experts are responding.
-- Stephanie Cajigal, Editor, Ob-Gyn/Women’s Health



Laparoscopic Hysterectomy

All material on this website is protected by copyright, Copyright © 1994-2016 by WebMD LLC. This website also contains material copyrighted by 3rd parties.